top of page
Multisystem Processes & Disorders
Complement pathways and deficiency syndromes
Core Principle of Complement System
🧷
The complement system is a cascade of plasma proteins that forms a critical bridge between innate and adaptive immunity, providing three main functions: opsonization of pathogens, direct lysis via membrane attack complex (MAC), and generation of inflammatory mediators.
🧷
Three pathways converge at C3: classical (antibody-mediated), lectin (mannose-binding), and alternative (spontaneous). All three ultimately generate C5 convertase → MAC formation.
🧷
Complement proteins are synthesized primarily in the liver and circulate as inactive zymogens that undergo sequential proteolytic activation.
🧷
Board pearl: The complement system is not just about pathogen killing — it's equally important for clearing immune complexes and apoptotic cells, explaining why deficiencies cause both infections AND autoimmunity.

Classical Pathway Activation and Components
📍
Initiated by C1q binding to Fc regions of IgM (single pentameric molecule) or IgG (requires ≥2 IgG molecules in close proximity).
📍
C1q + C1r + C1s form the C1 complex → C1s cleaves C4 and C2 → C4b2a complex (C3 convertase) → cleaves hundreds of C3 molecules.
📍
C4b2a3b becomes C5 convertase → initiates MAC assembly.
📍
Board pearl: Classical pathway requires antibody-antigen complexes, making it part of adaptive immunity. IgM is more efficient than IgG because one pentameric IgM can activate C1q, while IgG needs multiple molecules.
📍
C1 inhibitor (C1-INH) regulates this pathway by inactivating C1r and C1s.

Lectin Pathway: Antibody-Independent Recognition
🔹
Activated by mannose-binding lectin (MBL) or ficolins binding to carbohydrate patterns on microbial surfaces — no antibodies required.
🔹
MBL associates with MBL-associated serine proteases (MASPs), which are structurally similar to C1r and C1s.
🔹
Once activated, MASPs cleave C4 and C2, generating the same C3 convertase (C4b2a) as the classical pathway.
🔹
This represents innate immunity — recognizing pathogen-associated molecular patterns without prior exposure.
🔹
Board pearl: Lectin pathway deficiency (especially MBL deficiency) is common but usually asymptomatic unless combined with other immunodeficiencies.

Alternative Pathway: Spontaneous Activation
⭐
Continuously active at low levels through spontaneous C3 hydrolysis (C3 tick-over), creating C3(H₂O) which binds factor B.
⭐
Factor D cleaves bound factor B → C3(H₂O)Bb acts as initial C3 convertase → generates C3b.
⭐
C3b binds factor B → factor D cleaves → C3bBb (alternative pathway C3 convertase).
⭐
Properdin stabilizes C3bBb, extending its half-life.
⭐
Board pearl: Alternative pathway serves as both an independent activation route AND an amplification loop for all pathways — even classical/lectin activation generates C3b that feeds into alternative pathway.

Regulation and Host Protection
✅
Host cells express regulatory proteins that prevent complement-mediated damage: DAF (CD55), CD46 (MCP), and CD59.
✅
DAF and CD46 accelerate decay of C3 convertases; CD59 prevents MAC insertion.
✅
Soluble regulators include factor H (alternative pathway), C4-binding protein (classical/lectin), and C1-INH.
✅
Factor I cleaves C3b and C4b when bound to cofactors (factor H, CD46, C4BP).
✅
Board pearl: Deficiency of regulatory proteins → complement attacks host cells. Paroxysmal nocturnal hemoglobinuria (PNH) results from loss of GPI-anchored DAF and CD59 on RBCs.

Membrane Attack Complex Formation
🧠
C5 convertase cleaves C5 → C5a (anaphylatoxin) + C5b (initiates MAC).
🧠
Sequential binding: C5b + C6 + C7 → membrane insertion → C8 binding → polymerization of 10-16 C9 molecules.
🧠
C9 polymerization forms the transmembrane pore causing osmotic lysis.
🧠
MAC is particularly effective against gram-negative bacteria (especially Neisseria) due to their outer membrane structure.
🧠
Board pearl: Terminal complement deficiencies (C5-C9) specifically predispose to recurrent Neisseria infections — meningococcal and gonococcal disease.

Anaphylatoxins and Inflammation
⚡
C3a, C4a, and C5a are small peptides released during complement activation with potent inflammatory effects.
⚡
C5a > C3a >> C4a in biological potency.
⚡
Functions: mast cell/basophil degranulation, neutrophil chemotaxis and activation, increased vascular permeability, smooth muscle contraction.
⚡
C5a is the most powerful neutrophil chemoattractant in the body.
⚡
Board pearl: In septic shock, excessive C5a generation contributes to capillary leak, hypotension, and organ dysfunction. Anti-C5a therapies are under investigation.

C3 Deficiency: The Central Defect
📌
C3 is the convergence point of all pathways — its deficiency causes the most severe phenotype.
📌
Presents in infancy with recurrent, severe pyogenic infections (especially encapsulated bacteria: S. pneumoniae, H. influenzae, N. meningitidis).
📌
Also develop immune complex disease (glomerulonephritis, vasculitis) due to impaired clearance.
📌
Absent CH50 AND AH50 (both pathways require C3).
📌
Board pearl: C3 deficiency combines features of both early (infections) and late (immune complex disease) complement defects because C3 is essential for both opsonization and immune complex solubilization.

Early Classical Pathway Deficiencies (C1, C4, C2)
📣
C1q, C1r, C1s deficiencies: severe lupus-like syndrome with childhood onset, often with neurologic involvement.
📣
C4 deficiency: SLE-like disease, but C4 has two genes (C4A and C4B) so complete deficiency is rare.
📣
C2 deficiency: most common complement deficiency in Caucasians. Variable presentation — some asymptomatic, others develop SLE or recurrent infections.
📣
Mechanism: impaired immune complex clearance → tissue deposition → inflammation.
📣
Board pearl: Early classical pathway defects → lupus-like disease. The earlier the defect (C1q > C4 > C2), the more severe the lupus phenotype.

Terminal Pathway Deficiencies (C5-C9)
🔸
Present with recurrent Neisseria infections (meningococcal meningitis, disseminated gonococcal infection).
🔸
First infection typically occurs in late childhood/adolescence, not infancy.
🔸
Infections may be less severe than in normal hosts (less inflammation), but more frequent.
🔸
Normal immune complex clearance — no increased autoimmunity.
🔸
Board pearl: Recurrent meningococcal disease or disseminated gonococcal infection in an otherwise healthy person → screen for terminal complement deficiency with CH50.

Properdin and Factor D Deficiency
🧷
Only X-linked complement deficiency (all others are autosomal recessive).
🧷
Properdin stabilizes alternative pathway C3 convertase; deficiency → severe, often fatal meningococcal disease.
🧷
Factor D deficiency is extremely rare but causes similar susceptibility to Neisseria.
🧷
These deficiencies affect only the alternative pathway, so CH50 is normal but AH50 is absent.
🧷
Board pearl: Young male with severe meningococcal disease and normal CH50 → consider properdin deficiency (X-linked).

Complement Regulatory Protein Deficiencies
📍
C1-INH deficiency → hereditary angioedema (HAE): episodic swelling without urticaria, triggered by trauma/stress.
📍
Factor H deficiency → uncontrolled alternative pathway activation → atypical hemolytic uremic syndrome (aHUS) and dense deposit disease.
📍
Factor I deficiency → consumption of C3 and factor B → secondary C3 deficiency phenotype.
📍
CD59 deficiency → chronic hemolysis (similar to PNH but inherited, not acquired).
📍
Board pearl: Angioedema without urticaria that doesn't respond to antihistamines/steroids → think HAE from C1-INH deficiency.

Hereditary Angioedema: Mechanism and Features
🔹
C1-INH deficiency → uncontrolled activation of contact system (kallikrein-bradykinin) and complement.
🔹
Bradykinin is the primary mediator of swelling (not histamine).
🔹
Type I HAE (85%): low C1-INH level and function; Type II (15%): normal level but nonfunctional protein.
🔹
Episodic swelling of face, extremities, GI tract (abdominal pain), and potentially fatal laryngeal edema.
🔹
Board pearl: HAE shows low C4 even between attacks (diagnostic clue), while C1q is normal (distinguishes from acquired C1-INH deficiency).

Atypical HUS and Complement
⭐
Caused by mutations in complement regulatory proteins (factor H, factor I, CD46) or activating mutations in C3 or factor B.
⭐
Uncontrolled complement activation on endothelial cells → microangiopathic hemolytic anemia, thrombocytopenia, acute kidney injury.
⭐
Distinguished from typical HUS (Shiga toxin-mediated) by absence of preceding diarrhea.
⭐
Often triggered by infection, pregnancy, or medications.
⭐
Board pearl: Microangiopathic hemolytic anemia + thrombocytopenia + AKI without diarrhea in an adult → consider complement-mediated aHUS.

Laboratory Assessment of Complement
✅
CH50 (classical pathway): screens C1 through C9; absent in any classical or terminal pathway deficiency.
✅
AH50 (alternative pathway): screens factor B, D, properdin, C3, and C5-C9; specific for alternative pathway defects.
✅
Individual component levels: ordered based on CH50/AH50 results to identify specific deficiency.
✅
Low C3 with normal C4 suggests alternative pathway activation; low C4 with normal C3 suggests early classical pathway defect.
✅
Board pearl: CH50 = 0 means complete deficiency of at least one component; low but detectable CH50 suggests consumption.

Complement in Glomerulonephritis
🧠
Low C3 + low C4: lupus nephritis, cryoglobulinemia, endocarditis-associated GN (classical pathway activation).
🧠
Low C3 + normal C4: post-streptococcal GN, C3 glomerulopathy, aHUS (alternative pathway activation).
🧠
Normal C3 + C4: IgA nephropathy, pauci-immune GN (ANCA-associated), anti-GBM disease.
🧠
C3 nephritic factor: autoantibody stabilizing C3 convertase → persistent alternative pathway activation → dense deposit disease.
🧠
Board pearl: Complement levels help narrow the differential in glomerulonephritis — low C3 alone suggests alternative pathway diseases.

Complement and Infections
⚡
Encapsulated bacteria (especially Neisseria, S. pneumoniae, H. influenzae) are most problematic in complement deficiency.
⚡
Early component defects: broader susceptibility including S. aureus, Streptococcus.
⚡
Terminal defects: specifically Neisseria (need MAC for efficient killing).
⚡
Complement-deficient patients may not mount typical inflammatory responses → infections may present atypically.
⚡
Board pearl: Complement deficiency + encapsulated organism sepsis → give immediate antibiotics AND consider prophylaxis/vaccination after recovery.

Clinical Management Principles
📌
Vaccination is critical: meningococcal (all serogroups), pneumococcal, H. influenzae type b, with boosters as recommended.
📌
Prophylactic antibiotics considered for some deficiencies (especially properdin deficiency).
📌
Immediate antibiotics for fever given impaired host defense.
📌
Screen family members (autosomal recessive inheritance for most).
📌
For HAE: avoid ACE inhibitors (increase bradykinin), trauma prevention, C1-INH replacement or kallikrein inhibitors for acute attacks.
📌
Board distinction: Complement deficiency → vaccinate aggressively but antibody responses may be suboptimal due to impaired B cell activation.

Board Question Stem Patterns
📣
Recurrent meningococcal meningitis in a teenager → terminal complement deficiency.
📣
Severe childhood-onset SLE with low CH50 and normal AH50 → early classical pathway deficiency.
📣
Angioedema without urticaria, positive family history, low C4 → hereditary angioedema.
📣
Post-infectious glomerulonephritis with isolated low C3 → alternative pathway activation.
📣
Hemolytic anemia + thrombocytopenia + AKI without diarrhea → atypical HUS from complement dysregulation.
📣
X-linked inheritance pattern with severe meningococcal disease → properdin deficiency.
📣
Absent CH50 and AH50 → C3 deficiency.

One-Line Recap
🔸
The complement cascade (classical/antibody-mediated, lectin/carbohydrate-recognition, alternative/spontaneous) converges at C3 to generate opsonins, inflammatory mediators, and MAC, with early deficiencies causing lupus-like disease from impaired immune complex clearance, terminal deficiencies causing Neisseria susceptibility from absent MAC, and regulatory defects causing angioedema or complement-mediated tissue injury.

bottom of page

